Barrier Therapeutics Email Formats
Pharmaceutical Manufacturing • 
United States • 21-50 Employees
Barrier Therapeutics Email Formats
Barrier Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
Key Contacts at Barrier Therapeutics
Kelly Sutt
Franchise Director, Marketing
Tom Yajcaji
Director, Qa And Regulatory Compliance
Nicole Eyben
Managing Director
Partha Banerjee
Director
Steve Smith
Group Franchise Director
Guillermo Tous
Sr. Director
Lynne Bulger
Director
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 3254 |
| Founded | 2002 |
| Employees | 21-50 |
| Socials |
About Barrier Therapeutics
was a pharmaceutical company, engaged in the discovery, development, and commercialization of pharmaceutical products in the field of dermatology. Marketed products are Vusion, Xolegel and Solagé It was acquired by Stiefel Laboratories in August 2008.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Barrier Therapeutics has 21 employees across 7 departments.
Departments
Number of employees
Funding Data
Barrier Therapeutics has never raised funding before.
France
United Arab Emirates
United Kingdom
Frequently asked questions
4.8
40,000 users
